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Abstract 
Background: Cholesterol, the precursor of all steroid hormones, is the most abundant steroid in vertebrates and 
exhibits highly hydrophobic properties, rendering it a difficult substrate for aqueous microbial biotransformations. In 
the present study, we developed a Bacillus megaterium based whole-cell system that allows the side-chain cleavage 
of this sterol and investigated the underlying physiological basis of the biocatalysis.
Results: CYP11A1, the side-chain cleaving cytochrome P450, was recombinantly expressed in the Gram-positive 
soil bacterium B. megaterium combined with the required electron transfer proteins. By applying a mixture of 
2-hydroxypropyl-β-cyclodextrin and Quillaja saponin as solubilizing agents, the zoosterols cholesterol and 7-dehy-
drocholesterol, as well as the phytosterol β-sitosterol could be efficiently converted to pregnenolone or 7-dehydro-
pregnenolone. Fluorescence-microscopic analysis revealed that cholesterol accumulates in the carbon and energy 
storage-serving poly(3-hydroxybutyrate) (PHB) bodies and that the membrane proteins CYP11A1 and its redox 
partner adrenodoxin reductase (AdR) are likewise localized to their surrounding phospholipid/protein monolayer. The 
capacity to store cholesterol was absent in a mutant strain devoid of the PHB-producing polymerase subunit PhaC, 
resulting in a drastically decreased cholesterol conversion rate, while no effect on the expression of the recombinant 
proteins could be observed.
Conclusion: We established a whole-cell system based on B. megaterium, which enables the conversion of the ster-
oid hormone precursor cholesterol to pregnenolone in substantial quantities. We demonstrate that the microorgan-
ism’s PHB granules, aggregates of bioplastic coated with a protein/phospholipid monolayer, are crucial for the high 
conversion rate by serving as substrate storage. This microbial system opens the way for an industrial conversion of 
the abundantly available cholesterol to any type of steroid hormones, which represent one of the biggest groups of 
drugs for the treatment of a wide variety of diseases.
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Background
The chemical cleavage of a carbon–carbon bond is 
extremely difficult to execute, due to the inertness of 
these highly thermostable bonds and the constraint spa-
tial properties of its σ-orbitals [1]. There are, however, 
several enzymes that can specifically catalyze this reac-
tion type, a prime example being the cytochrome P450 
11A1, which is able to cleave the non-activated side-
chain of cholesterol [2], leading to pregnenolone, the 
central compound in the biogenesis of steroid hormones 
in all vertebrates. Its derivatives build a group of about 
300 approved steroid drugs which are commonly used 
for the treatment of a variety of diseases since the 1950’s 
[3]. For example, glucocorticoids are administered for 
Open Access
*Correspondence:  f.hannemann@mx.uni-saarland.de 
1 Centre for Human and Molecular Biology, Institute of Biochemistry, 
Saarland University, 66123 Saarbrücken, Germany
Full list of author information is available at the end of the article
Page 2 of 13Gerber et al. Microb Cell Fact  (2015) 14:107 
the treatment of rheumatoid arthritis, asthma, eczema, 
anaphylactic shock, and Addison’s disease; steroidal sex 
hormones for the treatment of male sexual organ dys-
function, gynecopathy and for contraception; and ana-
bolic steroid hormones for the treatment of diuresis, 
sinusitis and the improvement of protein metabolism.
Owing to the great demand for steroidal drugs, the 
production developed steadily since Merck first intro-
duced cortisone as a drug [4]. Today, the steroid pro-
duction represents one of the largest sectors of medical 
products manufactured by the pharmaceutical industry 
and is one of the best examples of the successful com-
bination of chemical and microbial technology in large 
scale industrial processes. Although some of the applied 
microbial conversions are well-established, efforts are 
ongoing either to improve the existing bioconversions 
or to develop new economically interesting processes 
such as the microbial side-chain cleavage of natural 
sterols to produce pregnenolone. The application of 
low-cost extracts of the most abundant sterol choles-
terol or its plant-derived analogs as substrates has been 
hindered so far by the hydrophobic nature of these sub-
stances and, subsequently, their low uptake rate into 
microbial cells. Hence, to the best our knowledge, so far 
no recombinant whole-cell system has been described, 
which can efficiently convert these compounds to preg-
nenolone. Attempts to utilize recombinant E. coli for 
pregnenolone production yielded only product concen-
trations in the µg/L range after 24 h [5]. In recent years, 
efforts have been made to produce steroid hormones in 
Saccharomyces cerevisiae by engineering the sterol bio-
synthesis pathway of the organism itself and thus endog-
enously providing the substrates for the recombinant 
enzymes [6–8]. However, this leads to the accumulation 
of unwanted side-products like ergosterol and brassicas-
terol that cannot be converted to pregnenolone [9] by 
CYP11A1, due to the presence of a double bond between 
carbon atoms 20 and 22 in the side-chain of these sub-
strates, resulting in a reduced efficiency of the whole-cell 
system.
The selected host in this work, Bacillus megaterium, 
is an aerobic, Gram-positive bacterium, which is mostly 
found in soil. In the past two decades this non-patho-
genic microorganism has gained attention as a host for 
biotechnological applications owing to its high capacity 
for recombinant protein production, high plasmid stabil-
ity and broad range of substrates [10]. Additionally, its 
large cell size with a 100-fold higher volume compared 
to Escherichia coli cells allows detailed microscopic stud-
ies [11]. We constructed a B. megaterium strain that 
recombinantly produces bovine CYP11A1 and its redox 
partners adrenodoxin (Adx) and adrenodoxin reductase 
(AdR) [12].
CYP11A1 belongs to the large and diverse superfam-
ily of P450 enzymes that act as external monooxygenases 
and catalyze a broad variety of reactions. They activate 
molecular oxygen through their heme iron and catalyze 
the oxidation of organic substances during biotransfor-
mation of xenobiotics, metabolic activation of carcino-
gens and biosynthesis of steroids [13, 14]. CYP11A1, as 
a mitochondrial P450 enzyme, receives the necessary 
electrons for catalysis from NADPH via a typical class I 
redox system [15], in which the [2Fe2S] ferredoxin Adx 
transfers electrons from an NADPH-dependent ferre-
doxin reductase, AdR, to the heme iron in CYP11A1. The 
terminal electron acceptor CYP11A1 takes up the water-
insoluble cholesterol at the inner mitochondrial mem-
brane and converts it to the less hydrophobic product 
pregnenolone, removing the unpolar side chain by cleav-
ing the 20,22 bond of the steroid. This reaction is mainly 
carried out in the male and female reproductive tissues 
and the adrenal gland and represents the first, rate-lim-
iting and hormonally regulated step in the synthesis of 
all steroid hormones in mammals. Pregnenolone is the 
precursor of all glucocorticoids, mineralocorticoids, and 
steroidal sex hormones. In addition, pregnenolone serves 
as a neurosteroid, involved in memory and neurological 
recovery by promoting microtubule polymerization and 
cell migration [16]. CYP11A1 is also expressed in the 
human skin, forming a metabolically active barrier by 
activating or inactivating biologically relevant molecules. 
The enzyme transforms 7-dehydrocholesterol (7DHC), 
the precursor of vitamin D3, to 7-dehydropregnenolone 
(7DHP), whose photo-transformed 5,7-diene derivatives 
exhibit an anti-proliferative effect against melanoma and 
leukemia cells [17].
The efficient substrate conversion presented in this 
work is based on the presence of granules in the cyto-
sol of B. megaterium [18–20], predominantly containing 
poly(3-hydroxybutyrate) (PHB), a form of polyhydroxy-
alkanoic acid (PHA). These natural water-insoluble 
inclusions are formed by various bacteria and serve as 
carbon and energy storage during times of oversupply 
with carbon sources. They are complex subcellular orga-
nelles consisting of a PHB core surrounded by a mon-
olayer of phospholipids and essential proteins for PHA 
metabolism [21]. These proteins are responsible for the 
biosynthesis or the degradation of PHA and include 
subunits of the PHA synthase, phasins, PHA depolymer-
izing enzymes, and regulatory proteins [22, 23]. Among 
them, PHA synthase is the key enzyme of PHA synthe-
sis. It accepts coenzyme A thioesters of hydroxyalkanoic 
acids (HA) as substrates and catalyzes the polymerization 
of HAs into PHA while simultaneously releasing CoA. 
PHA synthases currently are divided into four classes 
depending on their subunit composition and substrate 
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specificity, whereas Bacillus sp. express dimeric class 
IV PHA synthases consisting of the subunits PhaC and 
PhaR, respectively.
Due to their interesting physical and material proper-
ties the polyesters derived from PHB granules are con-
sidered for several applications in medicine, pharmacy, 
agriculture as well as the packaging and food industry 
[24]. The granules have also attracted interest for the pro-
duction of biocompatible and biodegradable nanoparti-
cles, which can be applied for drug delivery, diagnostics, 
bioseparation and protein immobilization [25].
In the present paper, we are demonstrating the effi-
cient in  vivo conversion of cholesterol or analogs by a 
recombinant microorganism, utilizing the bacterium’s 
PHB granules for substrate storage and embedding of 
the heterologous membrane proteins, without modifying 
these proteins with additional affinity tags. This biocata-
lyst system allows the production of the steroid precur-
sor pregnenolone starting from low-cost crude extracts 
of cholesterol or plant-derived sterols like β-sitosterol 
or campesterol. After this crucial step, pregnenolone 
can further be transformed to a variety of desired end-
products either by chemical means or by the application 
of further steroid converting enzymes.
Results
Establishment of a whole‑cell system for the conversion 
of cholesterol and analogs using Bacillus megaterium
In order to provide B. megaterium with the ability to 
perform the side-chain cleavage reaction on steroids, we 
transformed protoplasts of the strain MS941 (DSMZ: 
German Collection of Microorganisms and Cell Cul-
tures) with the tricistronic vector pSMF2.1_SCCAA. 
This plasmid contains an operon consisting of genes for 
bovine CYP11A1 as well as its natural redox partners 
Adx and AdR under the control of a xylose-inducible 
promoter (Fig. 1a). Three model substrates were chosen 
for a potential whole-cell conversion with this recombi-
nant strain: the zoosterols cholesterol and 7-dehydrocho-
lesterol (7-DHC) as well as the phytosterol β-sitosterol 
(Fig.  1b–d, insets). All steroids were dissolved in an 
aqueous solution of 2-hydroxypropyl-β-cyclodextrin and 
Quillaja saponin. Simultaneous to protein induction, the 
substrate solution was added to the shake-flask culti-
vated recombinant B. megaterium strain. As assessed by 
RP-HPLC, remarkably high pregnenolone and 7-dehy-
dropregnenolone yields of 95  mg  L−1  48  h−1 could be 
achieved when using cholesterol or 7-DHC, respectively 
(Fig. 1b, c), which corresponds to a conversion of approx-
imately 116 mg L−1 48 h−1 (300 µM) of these substrates 
(Fig. 1f ). The phytosterol β-sitosterol was converted to a 
lesser extent (Fig. 1d), with a conversion rate of 25 mg L−1 
48 h−1 (Fig. 1f ). As illustrated in Fig. 1e, the addition of 
Quillaja saponin to the culture with a final concentration 
of 0.2% drastically increased the cholesterol conversion 
rate by 250%, demonstrating a new application of these 
naturally occurring surface-active glycosides for the per-
meabilization of bacterial membranes for steroidal com-
pounds. The untransformed host strain MS941 was not 
able to metabolize cholesterol (Additional file  1: Figure 
S1). Whole-cell produced pregnenolone and 7-dehydro-
pregnenolone were purified by preparative RP-HPLC and 
their structures confirmed by NMR spectroscopy against 
authentic standards.
Identification of PHB bodies as main catalytic sites 
in recombinant B. megaterium
To evaluate the localization of the recombinantly pro-
duced proteins as well as the substrate in the cells of 
B. megaterium, we conducted confocal laser scanning 
microscopic (CLSM) studies. Firstly, fusion genes of 
either cyp11A1, adx and adr with egfp were constructed 
via SOE-PCR and cloned into vector pSMF2.1. Bacil-
lus megaterium strain MS941 was transformed with the 
resulting plasmids pSMF2.1_CYP11A1eGFP, pSMF2.1_
AdxeGFP or pSMF2.1_AdReGFP (Additional file  1: Fig-
ures S1–S3). Figures 2a–c illustrate the localization of the 
fusion proteins in the cells. To visualize a potential mem-
brane localization of the recombinant proteins, an addi-
tional counterstaining with the fluorescent dye FM 4-64 
[26] was carried out, which interacts with the polar phos-
phate groups of the outer leaflet of plasma membranes. 
While Adx exhibited a cytosolic distribution (Fig. 2c), the 
naturally membrane-associated proteins CYP11A1 and 
AdR were localized to distinct structures spread through-
out the cells (Fig.  2a, b), which had a similar appear-
ance to the PHB-bodies, monolayer coated hydrophobic 
aggregates of bioplastic serving as carbon storage, which 
can be specifically stained with the oxazone dye Nile red 
[27]. The cultivation of B. megaterium in TB-medium 
resulted in sufficient PHB granule formation for micro-
scopic studies (Fig.  2d). Subsequently, fusion protein 
expressing strains were stained with Nile red. As shown 
in Fig.  2e, f, CYP11A1eGFP and AdReGFP localized to 
the PHB granules, providing evidence that both mem-
brane proteins autonomously associate with these struc-
ture, without the addition of affinity tags to the proteins’ 
sequence. In contrast, the fusion between the soluble 
Adx and eGFP exhibited a cytosolic distribution and no 
association with the PHB granules (Fig. 2g).
To follow the fate of the substrate, we incubated cells 
of B. megaterium MS941 with the fluorescent cholesterol 
analog 25-[N-[(7-nitro-2-1,3-benzoxadiazol-4-yl)methyl]
amino]-27-norcholesterol (25-NBD cholesterol) [28]. 
Again, this probe associated with the cells’ PHB gran-
ules (Fig. 2h), indicating that the substrate as well as the 
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Fig. 1 Characterization of B. megaterium (strain MS941) whole-cell system for the conversion of cholesterol and analogs. a Tricistronic vector 
pSMF2.1_SCCAA encoding side-chain cleavage enzyme CYP11A1 as well as redox partners AdR and Adx under the control of a xylose-inducible 
promoter (PxylA, promoter xylose utilization operon; xylR, xylose repressor; tetR, tetracycline resistance gene; ampR, ampicillin resistance gene). b 
HPLC-chromatograms of the conversion of cholesterol after 48 h (light gray strain MS941 transformed with pSMF2.1_SCCAA, black untransformed 
strain, S cholesterol, P pregnenolone, F flow-through peak). c HPLC-chromatograms of the conversion of 7-DHC after 48 h (light gray strain MS941 
transformed with pSMF2.1_SCCAA, black untransformed strain, S 7-DHC, P 7-DHP, F flow-through peak). d HPLC chromatograms of the conversion 
of β-sitosterol after 48 h (light gray strain MS941 transformed with pSMF2.1_SCCAA, black untransformed strain, S β-sitosterol, P pregnenolone, C 
campesterol contained in the sample as minor impurity, F flow-through peak). e Effect of different final concentrations of Quillaja saponin (inset) on 
product yield. The substrate was dissolved in a 45% 2-hydroxypropyl-β-cyclodextrin with varying saponin concentrations and added to the cultures 
directly after protein induction. Pregnenolone yield after cholesterol conversion was determined by HPLC. f Conversion rates of substrates choles-
terol, 7-DHC and β-sitosterol after 48 h. Error bars indicate standard deviation of triplicate biological experiments.
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membrane proteins CYP11A1 and AdR are localized to 
these storage compounds.
Deletion of PHA polymerase subunit PhaC: effect 
on cholesterol storage, PHB accumulation and in vivo 
conversion
In order to assess the role of the PHB-bodies in catalyz-
ing the whole-cell conversion of steroids in recombinant 
B. megaterium in more detail, we aimed to delete the 
gene encoding the PHA polymerase subunit PhaC [29] to 
eliminate the formation of PHB-granules.
In B. megaterium, deletion of genes can be achieved 
by transforming cells with a plasmid containing flank-
ing regions of the target gene [30]. Two homologous 
recombination events with each flanking region are 
required to replace the target gene with the deletion con-
struct (Fig.  3). Replication of the knockout plasmid can 
be prevented by cultivating cells at a non-permissive 
temperature, based on a temperature-sensitive origin of 
replication contained in this plasmid (Fig.  4a, b). How-
ever, this method alone proved to be inefficient for the 
deletion of phaC, since it resulted only in colonies still 
containing the full-length target gene. Therefore, a coun-
ter-selection system was established, based on a previ-
ously described method for Bacillus subtilis, making use 
of the uracil phosphoribosyltransferase (upp) gene [31]. 
The upp gene allows selection for cells that no longer 
possess the plasmid after the knockout procedure and 
are thus not sensitive to the highly toxic antimetabolite 
5-fluorouracil (5-FU). Since B. megaterium MS941 natu-
rally possesses this gene, at first a gene deletion mutant 
of this strain had to be created. Flanking regions of upp 
were cloned into the temperature-sensitive origin of 
replication-harboring vector pUCTV2 [30]. Cells of B. 
megaterium strain MS941 were transformed with the 
resulting vector pUCTV2_Δupp and underwent the 
knockout procedure, as described in the “Methods” sec-
tion. A colony was selected that was still able to grow on 
5-FU containing agar. The deletion of the genomic upp 
ORF was confirmed by PCR (Fig.  4c) and the resulting 
strain was designated as GHH1. Then, flanking regions 
of the PHA polymerase subunit phaC were cloned into 
the vector pUCTV2_Upp containing the intact upp gene. 
Strain GHH1 was transformed with the resulting plasmid 
pUCTV2_Upp_ΔphaC. The deletion of the phaC ORF 
was successfully verified by utilizing a combination of the 
Upp-counterselection and a PCR-screening (Fig. 4d). The 
resulting strain was designated as GHH3.
Cells of strain GHH3 stained with Nile red completely 
lacked PHB accumulation (compare Fig. 5a with Fig. 2d). 
Fig. 2 Localization of eGFP fused CYP11A1, AdR and Adx as well as 25-NBD cholesterol in cells of B. megaterium strain MS941 analyzed by confocal 
fluorescence microscopy. a–c CYP11A1eGFP, AdReGFP and AdxeGFP expressing cells, respectively, counterstained with FM 4-64. CYP11A1eGFP and 
AdReGFP form aggregates, while AdxeGFP is expressed in a soluble form. d Staining of untransformed cells with PHB specific dye Nile red. e–g Nile 
red staining of cells expressing CYP11A1eGFP, AdReGFP and AdxeGFP, respectively (merged images). From left to right: eGFP emission signal, Nile 
red emission signal, and overlay, showing overlapping signals in yellow. CYP11A1eGFP and AdReGFP are localized at the PHB granules, while Adx-
eGFP is present solely in the cytosol. h 25-NBD cholesterol accumulated in PHB bodies of cells. The number of single cells attached to one another 
via their peptidoglycane layer differs, leading to differently sized cell aggregates.
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To exclude a possible unspecific gene deletion that could 
lead to an absence of PHB production, cells of strain 
GHH3 were transformed with plasmid pSMF3_RBCP 
(Additional file  1: Figure S5), encoding the genes of the 
PHB-synthesis operon: PHA polymerase subunit phaR, 
acetoacetyl-CoA reductase phaB, polyhydroxyalkanoic 
acid inclusion protein phaP and the genomically deleted 
gene phaC. As expected, the chromosomal deletion of 
phac was complemented, resulting in a restored PHB 
production (Fig. 5b).
The new strain GHH3 was transformed with pSMF2.1_
CYP11A1eGFP. Surprisingly, the Nile red-stained cells 
of GHH3 expressing CYP11A1eGFP (Fig.  5c) displayed 
a similar distribution of the fusion protein in the bacte-
rium compared with the PHB-producing strain GHH1 
(Fig.  2e). We then expressed a fusion protein between 
eGFP and B. megaterium’s phasin phaP (Additional file 1: 
Figure S6), an amphiphilic protein associated with the 
PHB bodies’ monolayer, to assess whether the distri-
bution of CYP11A1eGFP in strain GHH3 is an artifact 
stemming from the heterologous origin of the protein. 
As displayed in Fig.  5d, e, similar to CYP11A1eGFP, 
phaPeGFP exhibited an indistinguishable distribution in 
GHH1 and GHH3, both stained with Nile red, irrespec-
tive of PHB production.
As the disabled PHB production of the strain had no 
apparent effect on the overexpression of CYP11A1, we 
subsequently incubated strain GHH3 with the substrate 
analog 25-NBD cholesterol. The microscopic analysis 
revealed that the cells had lost the ability to store the 
sterol when no PHB was present (Fig. 5f ).
Lastly, we investigated whether the impaired substrate 
storage in absence of PHB in B. megaterium cells has 
an effect on the in  vivo whole-cell cholesterol conver-
sion rate. We compared strain GHH3 with GHH1 and 
pSMF3_RBCP-containing GHH3, each one being trans-
formed with pSMF2.1_SCCAA, encoding the genes for 
CYP11A1, Adx and AdR. Figure  6 illustrates the preg-
nenolone yield for each strain normalized to the cell dry 
weight, to exclude a potential effect of the gene deletion 
on the growth of B. megaterium cells. The absence of 
PHB in cells of GHH3 led to no detectable product for-
mation after 24  h and an 88% decreased pregnenolone 
yield after 48  h compared with GHH1. The capacity to 
convert cholesterol was partly restored in strain GHH3 
transformed with the complementing PhaC encoding 
plasmid pSMF3_RBCP.
Discussion
With an annual worldwide production exceeding 
1,000,000 tons, steroid drugs are the second most mar-
keted medical agents next to antibiotics [32]. The bio-
technological steroid production is one of the best 
examples of the successful combination of microbial 
conversions and chemical reaction steps [1], since some 
specific modifications of the steroid skeleton cannot be 
performed by the latter. Examples of such reactions are 
stereo- and regioselective hydroxylations, dehydrogena-
tions, and the steroid side-chain cleavage presented in 
Fig. 3 Schematic representation of upp deletion. Flanking genomic 
regions A′ and B′ of the target gene were amplified and fused via 
SOE-PCR. The resulting deletion construct was cloned into vector 
pUCTV2. Bacillus megaterium was transformed with the resulting 
plasmid pUCTV2_Δupp and cultivated at 30°C. After two subsequent 
recombination events with each homologous fragment the deletion 
of upp was obtained. Incubation at the non-permissive temperature 
prevents replication of the plasmid containing the intact copy of the 
upp gene (orits, temperature-sensitive origin of replication; Pupp, pro-
moter uracil phosphoribosyltransferase; tetR, tetracycline resistance 
gene; upp, uracil phosphoribosyltransferase gene).
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this paper. Although there are many microorganisms of 
different taxa, which are able to convert cholesterol or 
phytosterols to androstenedione, androstadienedione or 
other C19-steroids, the efficient microbial conversion of 
these substrates to pregnenolone has not been described 
so far [33, 34]. The most abundant steroid in vertebrates, 
cholesterol, can be obtained in huge amounts by extrac-
tion of wool grease or bovine spinal cords [35].
In this study we developed a recombinant whole-cell 
catalyst that efficiently cleaves the side–chain of sterols, 
converting the substrates cholesterol and β-sitosterol to 
pregnenolone, and 7-dehydrocholesterol to 7-dehydro-
pregnenolone. In order to perform these reactions, the 
Gram-positive bacterium B. megaterium strain MS941 
served as a host for the expression of the bovine side-
chain cleavage enzyme CYP11A1 and its redox partners 
Adx and AdR under control of the inducible strong xylose 
promoter. The resulting recombinant strain converted 
each of the three substrates in our study to one specific 
product (Fig.  1b–d). NMR-spectroscopy confirmed that 
the expected products pregnenolone or 7-dehydropreg-
nenolone were formed with no visible side-product for-
mation. The addition of Quillaja saponin, a mixture of 
amphiphilic glycosides obtained from the ‘soap bark tree’ 
Quillaja saponaria [36] greatly improved the sterol con-
version rate (Fig.  1e). It has been demonstrated before 
that these compounds increase cholesterol solubility in 
aqueous solutions by micelle formation [37] and are able 
to form pores in biological membranes in complex with 
cholesterol [38]. We propose that saponins can facilitate 
the transport of cholesterol into the whole-cell system 
of B. megaterium without having detrimental effects on 
the cells, since cultures were still able to grow and con-
vert cholesterol up to 48 h after addition of the additive 
Fig. 4 Deletion of the counterselection marker upp and the PHA polymerase subunit gene phaC. a Vector pUCTV2_Δupp for the deletion of upp, 
containing flanking genomic regions upstream and downstream of the gene (upp A′ and upp B′). The temperature-sensitive origin of replication 
(orits) prevents replication of the plasmid above temperatures of 42°C (tetR, tetracycline resistance gene; ampR, ampicillin resistance gene). b Vector 
pUCTV2_Upp_ΔphaC for the deletion of phaC, containing flanking genomic regions upstream and downstream of the gene (phaC A′ and phaC 
B′). It additionally contains the gene for the uracil phosphoribosyltransferase (upp) under the control of its natural promoter (Pupp) which serves as 
a counterselection marker. c Agarose gel showing the PCR products using primers 9 and 10, flanking the upp gene and its promoter. Amplification 
with these primers results in DNA fragments of 865 bp size, if the upp-ORF is intact. The following templates were used: genomic DNA of MS941 
(lane 1), pUCTV2_ Δupp (lane 2) and genomic DNA of upp deletion strain GHH1 (lane 3). The resulting fragment contained the upp gene truncated 
by 600 bp (lane 3) compared to the full-length gene (lane 1) (lane M: smartladder DNA marker (Eurogentec). d Agarose gel showing the PCR prod-
ucts using flanking primers 11 and 14. These bind approximately 1,000 bp upstream and downstram of the target gene. Amplification with these 
primers results in DNA fragments of ca. 3,000 bp size, if the phaC-ORF is intact. The following templates were used: genomic DNA of strain GHH1 
(lane 1), pUCTV2_Upp_ΔphaC (lane 2) and genomic DNA of strain GHH3 (lane 3). The resulting fragment contained the phaC gene truncated by 
1,088 bp (lane 3) compared to the full-length fragment (lane 1) (lane M: smartladder DNA marker). Additional bands in lane 2 stem from the plasmid 
used as DNA template.
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in the early exponential phase, while maintaining their 
morphological integrity. Once the concentration of the 
additive was optimized (Fig.  1e), 300  µM of cholesterol 
were completely converted to pregnenolone in 48  h. 
These values have been reached under simple disconti-
nous shake-flask cultivation and already exceed the preg-
nenolone concentration described for high-cell density 
cultivation of recombinant S. cerevisae (~60 µM 48 h−1; 
[6]). Comparable systems for pregnenolone production 
do not exist. 7-DHC was converted with an equal rate, 
while β-sitosterol conversion was considerably lesser 
(Fig.  1f ). The reduced conversion rate of the latter is in 
congruence with published experiments using a recon-
stituted system containing purified CYP11A1, AdR and 
Adx displaying a 66% lower turnover number (kcat) of 
CYP11A1 for β-sitosterol (and 46% for campesterol) 
compared with cholesterol [39]. This may be attributed to 
the more branched side-chain of β-sitosterol, which pos-
sibly slows down its entry into the active site of CYP11A1 
and its movement during the three-step side-chain cleav-
age reaction. Site-directed mutagenesis of the CYP11A1 
gene to generate a protein providing more space for the 
bulky substrate might solve this problem in the future.
In order to elucidate the macromolecular basis for 
the efficient transfer and conversion of these hydropho-
bic substrates in B. megaterium, we firstly analyzed the 
localization of the recombinant proteins. B. megaterium 
strains were generated producing C-terminally tagged 
eGFP fusion proteins of CYP11A1, AdR and Adx. CLSM 
analysis revealed that AdxeGFP was localized in the 
Fig. 5 Effect of PHA polymerase subunit phaC knockout on morphology of strain GHH3. a Nile red stained ΔphaC strain GHH3 exhibits no accumu-
lation of PHB. b PHB production is restored in cells after transformation with phaC containing plasmid pSMF3_RBCP. c Strain GHH3 transformed with 
pSMF2.1_CYP11A1eGFP. Expressed CYP11A1eGFP forms aggregates in the cell. d, e Expression of phaPeGFP in GHH1 and GHH3, respectively, both 
stained with Nile red (overlay). f Fluorescent probe 25-NBD cholesterol is not stored in cells of strain GHH3 lacking PHB.
Fig. 6 Effect of disabled PHB formation on cholesterol conversion 
activity. Pregnenolone formation in PHB-producing strain GHH1 and 
PHB-devoid strain GHH3, both transformed with pSMF2.1_SCCAA. 
After 24 h no pregnenolone could be detected in cultures of strain 
GHH3. The product formation after 48 h was decreased by 88% in 
comparison to strain GHH1. As a control strain, GHH3 was co-trans-
formed with pSMF3_RBCP resulting in a restored PHB production and 
cholesterol conversion activity. Error bars indicate standard deviation 
of triplicate biological experiments.
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cytosol (Fig. 2g). This is in accordance with its function 
as a soluble protein shuttle, transferring electrons from 
AdR to CYP11A1. Surprisingly, CYP11A1 and AdR were 
shown to be localized at the PHB granules (Fig. 2e, f ), as 
demonstrated by Nile red staining.
PHB granules accumulate in the bacterium upon exces-
sive carbon supply in the medium and can be mobilized 
as a source of energy when carbon is limited [40]. The 
granules’ surface appears to provide an optimal envi-
ronment for the functional association of the mamma-
lian membrane proteins CYP11A1 and AdR. Although 
this result was unexpected, the principle association to 
a phospholipid monolayer is in accordance with their 
nature as membrane proteins.
We further investigated the localization of the sub-
strate in cells of B. megaterium utlizing the fluorescent 
analog 25-NBD cholesterol. As in the case of AdReGFP 
and CYP11A1eGFP, the probe accumulated in the PHB 
granules (Fig.  2h). Concluding from these findings, we 
proposed that B. megaterium can efficiently take up the 
substrate under the applied biotransformation conditions 
and that the highly hydrophobic core of the PHB gran-
ules is able to store cholesterol, which is subsequently 
converted by CYP11A1, associated with the surrounding 
monolayer.
To provide further evidence for this assumption, we 
aimed to disable the PHB granule production by delet-
ing the large PHA polymerase subunit encoding gene 
phaC, applying a new counter-selection system for B. 
megaterium. The resulting strain GHH3 was unable to 
produce PHB, as demonstrated by Nile red staining. The 
PHB production could be restored by transforming this 
strain with a plasmid encoding the PHB operon includ-
ing phaC, although the shape of the cells and granula dif-
fered from the wild type strain GHH1, possibly due to the 
overexpression of the PHB granules-synthesizing pro-
teins and the increased PHB accumulation.
Contrary to our expectation that CYP11A1 tagged with 
eGFP would now be localized at the bacterium’s mem-
brane, the fusion protein expressed in the PHB-devoid 
strain GHH3 still exhibited a similar aggregation pattern 
compared with strain GHH1, although no PHB gran-
ules should be present in the cells (Fig. 5c; cross-sections 
through cells of both strains are displayed in Additional 
file  1: Figure S7). According to the three existing mod-
els, activity of the PHA polymerase is necessary for the 
biogenesis of PHB granules in microorganisms [41–43]: 
the ‘micelle’ model suggests that PHB is produced in 
the cytosol and the monolayer coats the PHB when a 
certain size is reached, the ‘budding’ model states that 
PHB is produced in the intermembrane space, leading 
to a budding off the membrane and lastly the ‘scaffold’ 
model proposes that the PHB synthesis is initiated from 
the bacterial nucleoid, to which the required proteins 
are attached. We repeated the localization experiment 
overexpressing B. megaterium’s chromosomally encoded 
phasin phaP, a natural main constituent of the PHB gran-
ules’ monolayer responsible for size regulation, to assess 
whether the aggregation of CYP11A1eGFP is an artificial 
effect due to the protein’s heterologous nature. However, 
similar to CYP11A1eGFP, phasineGFP was expressed 
in aggregates in both GHH1 and GHH3 (Fig.  5d, e). It 
remains to be elucidated if the observed protein struc-
tures are ‘hollow’ PHB bodies, proteinaceous inclusion 
bodies or self-oligomerized protein complexes, e.g. by 
investigating the localization of other naturally PHB 
monolayer associated proteins. Self-oligomerization of 
the eGFP tag can be excluded, since AdxeGFP exhibits a 
cytosolic distribution.
In contrast to the CYP11A1 expression, accumulation 
of the cholesterol analog 25-NBD cholesterol inside the 
cells of PHB-lacking strain GHH3 was not observed, 
indicating that substrate storage and uptake is the crucial 
factor for the efficiency of the whole-cell system (Fig. 5f ).
To substantiate this finding, the in vivo cholesterol con-
version activity with strains GHH1and GHH3 expressing 
CYP11A1 and its redox partners was assessed (Fig.  6). 
The pregnenolone yield for the PHB-devoid strain was 
drastically decreased, but could be increased again after 
complementing the PHB formation in strain GHH3 by 
co-transformation with a plasmid encoding the PHB 
synthesis operon. Pregnenolone levels did not reach 
those of strain GHH1, which could be explained by lower 
expression levels of CYP11A1, Adx and AdR, as well as 
decreased NADPH availability due to the overexpres-
sion of the PHB synthesizing operon. In conclusion, the 
strongly impaired substrate storage observed by fluores-
cence microscopy is in congruence with the diminished 
cholesterol conversion rate in B. megaterium cells lacking 
PHB production.
Overall, our results provide evidence that the efficient 
conversion of cholesterol in the recombinant B. megate-
rium whole-cell system is based on the natural ability of 
the microorganism to form subcellular scaffolds in form 
of PHB granules. The core of these granules serves as 
storage for hydrophobic sterols, whereas the surface layer 
can host mammalian membrane proteins in an active 
form. This system was applied for the conversion of the 
hydrophobic substrates cholesterol and β-sitosterol to 
pregnenolone and 7-dehydrocholesterol to 7-dehydro-
pregnenolone, both pharmaceutically interesting start-
ing compounds for further steroid hormone production, 
by the side-chain cleaving cytochrome P450 CYP11A1. 
Taken together, B. megaterium is a particularly promis-
ing host for the expression of further cholesterol-metab-
olizing membrane proteins such as CYP27A1, CYP3A4 
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or CYP46A1 for biotechnological applications or the elu-
cidation of new products. In addition, it could generally 
serve as an expression platform for membrane proteins, 
such as microsomal Cytochromes P450 and be suitable 
for the bioconversion of hydrophobic substrates with an 
affinity for the PHA synthesized by this bacterium.
Conclusion
Cholesterol is the precursor molecule of all steroid hor-
mones, encompassing glucocorticoids, mineralocorti-
coids and sex steroids. Due to its extremely low solubility 
in water, an efficient microbial conversion has not been 
possible so far. In the present paper we describe a whole-
cell system based on the soil bacterium B. megaterium, 
which, by recombinantly expressing the side-chain cleav-
ing cytochrome P450 CYP11A1 and its redoxpartners, is 
able to efficiently convert cholesterol to pregenenolone, 
the central compound of steroidogenesis. We demon-
strate that the microorganism’s PHB granules, aggregates 
of bioplastic coated with a protein/phospholipid mon-
olayer, are crucial for the high conversion rate by serving 
as substrate storage. Furthermore, we provide evidence 
that the natural membrane proteins CYP11A1 and its 
redox partner AdR are attached to the granules’ mon-
olayer, implying that these structures can host eukaryotic 
membrane proteins in a properly folded state (Fig.  7). 
This microbial system allows the targeted microbial 
production of steroid hormones starting from the abun-
dantly available substrate cholesterol or analogs.
Methods
Molecular cloning
Sequences of the bovine genes encoding mature 
CYP11A1 (mutant K193E [44] based on NCBI Reference 
Sequence: NP_788817.1), AdR (NP_777116.1) and Adx 
(NP_851354.1) were codon-optimized for B. megaterium 
(http://www.jcat.de) and synthesized by Geneart AG 
(Regensburg, Germany). The resulting genes were cloned 
into shuttle vector pSMF2.1 [45] by using SpeI/MluI, 
KpnI/SacI and BsrGI/SphI restriction sites, respectively, 
resulting in plasmid pSMF2.1_SCCAA. All three genes 
are located in an operon under the control of the strong 
inducible promoter PxylA. Each gene contains its own 
ribosomal binding site. In E. coli, the ß-lactamase is pro-
duced, conferring ampicillin resistance. In B. megaterium, 
the tetracycline efflux pump is produced, conferring 
tetracycline resistance. Plasmids pSMF2.1_CYP11A1e-
GFP, pSMF2.1_AdReGFP and pSMF2.1_AdxeGFP 
encoding CYP11A1, AdR and Adx with a C-terminally 
fused eGFP tag (Additional file  1: Figures S2–S4) were 
constructed by SOE-PCR using the respective primers 
2a/3a, 2b/3b and 2c/3c in combination with primers 1 
and 4 and pSMF2.1_SCCAA and pEGFP-C1 (clontech) 
as templates. The resulting fused genes were cloned into 
pSMF2.1 with restrictions sites SpeI and MluI. The fusion 
gene encoding phaPeGFP (Additional file  1: Figure S6) 
was constructed by SOE-PCR using primers 21-24 with 
genomic B. megaterium DNA pEGFP-C1 (clontech) 
as templates. The resulting fragment was cloned into 
pSMF2.1 using PacI and SpeI restriction site resulting in 
vector pSMF2.1_phaPeGFP. Vector pUCTV2_Δupp was 
constructed by cloning flanking regions A’ and B’ into 
vector pUCTV2 via BamHI sites. The deletion construct 
was created by SOE-PCR using genomic DNA of B. 
megaterium strain MS941 as template and primers 5, 6, 
7 and 8. Vector pUCTV2_Upp_ΔphaC was constructed 
by cloning the full-length upp gene and its natural pro-
moter into pUCTV2 using a BamHI site, after amplifying 
the fragment by PCR using genomic DNA of B. megate-
rium strain MS941 and primers 9 and 10. The deletion 
construct containing A’ and B’ was amplified and fused 
by SOE-PCR using genomic DNA as template and prim-
ers 11, 12, 13 and 14, then ligated into plasmid pUCTV2_
Upp via the EcoRI restriction site. Vector pSMF3_RBCP 
was constructed by ligating two PCR fragments sequen-
tially into the vector pMGBm19 [46] via the restriction 
sites XhoI, MluI and SacI. The first fragment compris-
ing the operon of phaR, phaB and phaC under control 
of the natural promoter PphaR and the second fragment 
comprising the phaP gene were amplified using genomic 
Fig. 7 Summary illustration. In cells of recombinant B. megaterium, 
the membrane proteins CYP11A1 and AdR are localized to the PHB 
granule-surrounding monolayer. Adx is localized to the cytosol, serv-
ing as an electron shuttle between CYP11A1 and AdR. Cholesterol is 
stored inside the PHB core and can be delivered to CYP11A1. After 
undergoing the side-chain cleavage, the product pregnenolone is 
released from the cell.
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DNA of B. megaterium strain MS941 and primers 15, 16, 
17 and 18 resulting in the new operon PphaR-phaR-phaB-
phaC-phaP (Additional file 1: Figure S5).
Sequences of all primers are listed in Additional file 1: 
Table S1. Strains and plasmids used in this study are 
listed in Additional file 1: Tables S2, S3. All cloning exper-
iments were performed with E. coli strain Top10 (Invitro-
gen). Plasmids were prepared using Nucleospin Plasmid 
QuickPure kit (Macherey & Nagel). Genomic DNA was 
extracted by Genomic DNA Extraction kit (nexttec). 
Ligations were carried out using FastLink DNA Ligase kit 
(Epicentre Biotechnologies). All restriction enzymes were 
purchased from New England Biolabs. Bacillus megate-
rium cells were transformed according to the PEG-medi-
ated protoplast transformation method [47].
B. megaterium cultivation conditions
Either LB- (25  g/L, Becton–Dickinson) or TB- (24  g/L 
yeast extract, 12  g/L tryptone, 0.4% glycerol, 100  mM 
potassium phosphate buffer, pH 7.4) media were used 
for the cultivation of B. megaterium. For the preculture, 
50  mL of medium either containing 10  µg/mL tetracy-
cline (cells harboring a variant of pSMF2.1) or 10 µg/mL 
chloramphenicol (cells harboring a variant of pSMF3) 
were inoculated with cells from an agar plate or glycerol 
stock. For the main culture, 50 mL of medium contain-
ing 10 µg/mL of the required antibiotic were inoculated 
with 500  µL of the preculture. The main culture was 
grown until an optical density of ~0.4 was reached, pro-
tein expression was induced by addition of 0.25 g xylose 
dissolved in 1 mL distilled water. For whole-cell conver-
sion experiments, substrates were dissolved in a 45% 
2-hydroxypropyl-β-cyclodextrin/4% Quillaja saponin-
solution. 2.5 mL of the solution were added to the culture 
directly after protein induction. A final substrate con-
centration of 300 µM was used for all conversion experi-
ments. Cholesterol from sheep wool (purity ≥99%), 
7-dehydrocholesterol (≥98%), β-sitosterol from plant 
extracts (purity ≥70%, containing residual campesterol), 
2-hydroxypropyl-β-cyclodextrin (average molecular 
weight ~1,460) and Quillaja saponin (Sapogenin content 
≥10%) were purchased from Sigma-Aldrich.
Sample treatment and RP‑HPLC analysis
Steroids without intrinsic absorption were converted into 
their Δ4-3-keto-derivatives prior to RP-HPLC analysis, 
to allow photometric detection at 240 nm. 1 mL culture 
samples were boiled in water for 1 min. 20 µL cholesterol 
oxidase solution (5 mg cholesterol oxidase (Calbiochem) 
and 5  mg Na-cholate dissolved in 5  mL 50  mM HEPES 
buffer pH 7, containing 0.05% Tween-20) were added and 
the sample was incubated at 37°C with 1,000 rpm shaking 
for 1 h. For RP-HPLC analysis, the sample was extracted 
twice with 1  mL ethylacetate and the extract was dis-
solved in acetonitrile. Samples were analyzed isocrati-
cally with pure acetonitrile using a NUCLEODUR 100-3 
C18 column (Macherey & Nagel). Samples containing 
cholestenone and β-sitostenone were detected at 240 nm 
wavelength, 7-DHC at 280 nm. A flow rate of 1 mL/min 
was applied. Progesterone yield was calculated by using 
a progesterone calibration curve. 7-Dehydropregne-
nolone yield was determined by dividing product peak 
area by total substrate/product peak area. To purify preg-
nenolone for NMR analysis after whole-cell conversion, 
200  mL culture medium were extracted and separated 
using a 250/8 NUCLEODUR 100-3 C18 column and the 
product collected.
Cell staining and confocal fluorescence microscopy
Bacillus megaterium was cultivated under the same con-
ditions as for the in  vivo conversion experiments. Prior 
to staining, culture samples were washed and centri-
fuged twice to diminish background fluorescence. 20 µL 
of cell suspension were spread on coverslips and fixed by 
air drying. For Nile red (Sigma-Aldrich) staining, drops 
of a solution of 1  mg/mL Nile red dissolved in etha-
nol were added to the coverslips, incubated for 10 s and 
rinsed with ethanol. For FM 4-64 (Invitrogen) staining 
drops of a solution of 1 mg/mL FM 4-64 dissolved in dis-
tilled water were added to the coverslips, incubated for 
10 s and rinsed with water. Samples were analyzed with 
a LSM 510 confocal microscope (Zeiss). Excitation and 
emission maxima for eGFP, Nile red and FM 4-64 are 
as follows (in nm): 488/509, 552/636 and 558/734. Cells 
were magnified 1,000× using immersion oil and digitally 
zoomed in, if necessary.
Gene deletion in B. megaterium
To delete the upp gene, B. megaterium MS941 was trans-
formed with the plasmid pUCTV2_Δupp containing the 
deletion construct. 50 mL LB medium containing 10 µg/
mL tetracycline were inoculated with transformed colo-
nies and incubated at 30°C and 180 rpm for 16 h. Culture 
samples were diluted 1:10 and spread out on minimal 
medium agar plates, based on modified Spizizen’s salts 
[48], and incubated at 30°C for 16 h. Colonies were then 
replica plated and incubated at 42°C for 16  h. Colonies 
containing a genomic deletion of the upp gene were able 
to grow on minimal agar plates containing 1  µM 5-FU. 
The truncation of the gene was verified by PCR, using 
primers 9 and 10. The resulting strain was named GHH1. 
The phaC gene was knocked out by transforming cells 
of strain GHH1 with plasmid pUCTV2_Upp_ΔphaC. 
50  mL LB medium containing 10  µg/mL tetracycline 
were inoculated with transformed colonies and incu-
bated at 30°C and 180 rpm for 16 h. Culture samples were 
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diluted 1:10, spread out on minimal medium agar plates 
and incubated at 30°C for 16  h. Colonies were replica 
plated on minimal agar plates containing 1 µM 5-FU and 
incubated at 42°C for 16 h. The resulting grown colonies 
either contained the full-length or truncated form of the 
phaC gene. Absence of PHB production was confirmed 
by Nile red staining and the gene deletion verified by 
PCR using primers 11 and 14. The resulting strain was 
designated as GHH3.
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